HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk
Fabry Disease Gene Therapy Clinical Trial Moves Onto Dosing Second Cohort

The FDA recently cleared Freeline Therapeutics to begin treating patients in the United States.

New, Multicenter Trial of MB-106 Doses First Patient

Interim data from an ongoing study demonstrate continuing efficacy in B-NHL, CLL, and FL.

CardiAMP Cell Therapy Yields 100% Response Rate in Heart Failure

The new, 2-year data is from a roll-in cohort of 10 patients presented at the HFSA 2022 meeting.

Treating Autoimmune Diseases With Smarter Cell Therapies

Karen Walker, chief technology officer, Kyverna Therapeutics, discussed the company’s CAR T-cell and regulatory T-cell technologies.

Gene Therapy Shows Promise in Leber Congenital Amaurosis

Significant improvements were reported in full-field stimulus testing.

Around the Helix: Cell and Gene Therapy Company Updates – October 5, 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.